Insider filing · BBIO
Andrew Lo
Director
profile →
BridgeBio Pharma, Inc.
BBIO · Healthcare · 74 filings in 24 months
ticker →
Andrew Lo sold $6.3M of BridgeBio Pharma (BBIO)
Executed Nov 17 2025, disclosed Nov 19 2025, 2 days later.
Value, as filed
$6.3M
95,599 sh across 4 lots
Executed
Nov 17 2025
the trade date, as filed
Disclosed
Nov 19 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
ALAndrew Lo (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in BridgeBio Pharma, Inc. (BBIO). The largest single filing was $6.3M of BBIO (95,599 sh across 4 lots, as filed), executed Nov 17 2025.
The name
BBIOHealthcare · BridgeBio Pharma, Inc., a biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Andrew Lo in BBIO
BBIOSALE
BridgeBio Pharma, Inc.
$3.9M100,000 sh × $38.50
Exec May 2 2025
Filed May 6 2025 · 5:30 PM ET